yes, that bit confused me too. The $3.04m = cash receipts (which we saw was in FY20 Receivables)...but they also say "Revenue for Q1 FY21 (unaudited) approx $2.5m"
And in the Appendix we see the cash receipt total only showing ($3.036m), right?
So, how are they counting past receivables as Q1 new revenue? OR is this all completely different...they haven't collected the past receivables at all..and the $2.5m is all 'new' revenue...which means the FY20 receivables is still pending?
The ann says only AccBio 259.2k devices ordered for initial stockpile...but they would presumably have sold some for HIV, FebriDx, whatever else....
Hmm...
I think I might write to AT1 and ask for clarification around the FY20 receivables status...is it in here or not?
